Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/5823

TDMS Study 89006-06 Pathology Tables

NTP Experiment-Test: 89006-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                                AZT                                            Date: 05/31/96
Route: GAVAGE                                                                                                     Time: 12:30:48

                                                        TWO-YEAR CHRONIC




       Facility:  Southern Research Institute

       Chemical CAS #:  30516-87-1

       Lock Date:  06/04/93

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All


































a  Number of animals examined microscopically at site and number of animals with lesion

                                                              Page   1

NTP Experiment-Test: 89006-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                                AZT                                            Date: 05/31/96  
Route: GAVAGE                                                                                                     Time: 12:30:48  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        VEHICLE      30 MG/KG     60 MG/KG     120                                       
                                                   CONTROL                                MG/KG                                     
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                 5            5            9            7                                     
    Natural Death                                     11            6            7           11                                     
    Dosing Accident                                                              2            1                                     
    Accidently Killed                                                            1                                                  
  Survivors                                                                                                                         
    Terminal Sacrifice                                34           38           31           31                                     
    Natural Death                                                   1                                                               
  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (50)         (49)         (50)         (50)                                   
      Necrosis                                                                                1 (2%)                                
      Muscularis, Inflammation, Chronic                                          1 (2%)       1 (2%)                                
   Intestine Large, Colon                             (46)         (48)         (46)         (45)                                   
      Inflammation, Chronic                                                      1 (2%)                                             
   Intestine Large, Cecum                             (46)         (47)         (46)         (45)                                   
      Hemorrhage                                                                              1 (2%)                                
      Inflammation, Chronic                                                                   1 (2%)                                
   Intestine Small, Duodenum                          (46)         (45)         (46)         (44)                                   
      Erosion                                                                    1 (2%)                                             
   Intestine Small, Jejunum                           (46)         (46)         (44)         (42)                                   
      Peyer's Patch, Hyperplasia, Lymphoid                          1 (2%)                                                          
   Intestine Small, Ileum                             (46)         (44)         (45)         (42)                                   
      Peyer's Patch, Hyperplasia, Lymphoid             1 (2%)                                                                       
   Liver                                              (50)         (50)         (50)         (50)                                   
      Angiectasis                                                   1 (2%)                                                          
      Basophilic Focus                                              1 (2%)                    3 (6%)                                
      Clear Cell Focus                                 1 (2%)       3 (6%)       1 (2%)                                             
      Eosinophilic Focus                               6 (12%)     16 (32%)      7 (14%)      7 (14%)                               
      Fibrosis, Focal                                                                         1 (2%)                                
      Hematopoietic Cell Proliferation                              1 (2%)       1 (2%)       1 (2%)                                
      Hepatodiaphragmatic Nodule                       1 (2%)                                                                       
      Inflammation, Chronic                            1 (2%)       2 (4%)       2 (4%)       1 (2%)                                
      Mixed Cell Focus                                 1 (2%)       1 (2%)       5 (10%)                                            
      Necrosis, Focal                                  3 (6%)       3 (6%)       2 (4%)      10 (20%)                               
      Vacuolization Cytoplasmic                        3 (6%)       4 (8%)       3 (6%)       3 (6%)                                
      Hepatocyte, Karyomegaly                          1 (2%)       1 (2%)                                                          
   Mesentery                                          (13)         (17)         (8)          (11)                                   
      Inflammation, Chronic                            1 (8%)                                 1 (9%)                                
      Fat, Necrosis                                    8 (62%)     16 (94%)      5 (63%)     10 (91%)                               
   Pancreas                                           (50)         (49)         (49)         (48)                                   
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    2                                                              
NTP Experiment-Test: 89006-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                                AZT                                            Date: 05/31/96  
Route: GAVAGE                                                                                                     Time: 12:30:48  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        VEHICLE      30 MG/KG     60 MG/KG     120                                       
                                                   CONTROL                                MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Atrophy                                          1 (2%)       1 (2%)       2 (4%)       1 (2%)                                
      Atrophy, Diffuse                                 1 (2%)                                                                       
      Inflammation, Chronic                                         2 (4%)                                                          
      Necrosis                                         1 (2%)                                                                       
      Duct, Cyst                                       2 (4%)       1 (2%)       1 (2%)       1 (2%)                                
   Stomach, Forestomach                               (49)         (49)         (49)         (49)                                   
      Cyst                                                          1 (2%)                                                          
      Erosion                                                                    1 (2%)                                             
      Hemorrhage                                                                 1 (2%)                                             
      Inflammation, Chronic                                         1 (2%)       2 (4%)                                             
      Ulcer                                                         1 (2%)       1 (2%)                                             
      Epithelium, Hyperplasia                          4 (8%)       9 (18%)      7 (14%)      3 (6%)                                
   Stomach, Glandular                                 (49)         (49)         (48)         (49)                                   
      Erosion                                          1 (2%)       2 (4%)       1 (2%)       1 (2%)                                
      Mineralization                                   1 (2%)                                 1 (2%)                                
      Necrosis                                                      1 (2%)                                                          
      Glands, Degeneration, Cystic, Focal              1 (2%)       1 (2%)       4 (8%)       4 (8%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (49)         (50)         (50)         (50)                                   
      Inflammation, Chronic, Focal                     1 (2%)       4 (8%)       3 (6%)       3 (6%)                                
      Mineralization                                                1 (2%)       1 (2%)                                             
      Thrombosis                                                                              1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (49)         (50)         (50)                                   
      Accessory Adrenal Cortical Nodule                                          1 (2%)                                             
      Cyst                                                                       1 (2%)                                             
      Cytoplasmic Alteration, Focal                                 4 (8%)       4 (8%)       2 (4%)                                
      Hematopoietic Cell Proliferation                                                        1 (2%)                                
      Hyperplasia, Focal                               1 (2%)                                 1 (2%)                                
      Hypertrophy, Focal                                            2 (4%)       1 (2%)       4 (8%)                                
   Islets, Pancreatic                                 (49)         (49)         (50)         (47)                                   
      Hyperplasia                                                                             2 (4%)                                
   Parathyroid Gland                                  (47)         (45)         (48)         (50)                                   
      Cyst                                                                       1 (2%)       1 (2%)                                
   Pituitary Gland                                    (46)         (49)         (46)         (46)                                   
      Angiectasis                                      1 (2%)       2 (4%)                    1 (2%)                                
      Pars Distalis, Cyst                                           1 (2%)                                                          
      Pars Distalis, Cytoplasmic Alteration, Focal     7 (15%)                   1 (2%)       3 (7%)                                
      Pars Distalis, Hyperplasia, Focal                4 (9%)       7 (14%)      6 (13%)      5 (11%)                               
      Pars Intermedia, Hyperplasia, Focal                                                     2 (4%)                                
   Thyroid Gland                                      (49)         (50)         (50)         (50)                                   
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    3                                                              
NTP Experiment-Test: 89006-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                                AZT                                            Date: 05/31/96  
Route: GAVAGE                                                                                                     Time: 12:30:48  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        VEHICLE      30 MG/KG     60 MG/KG     120                                       
                                                   CONTROL                                MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Degeneration, Cystic, Focal                     25 (51%)     19 (38%)     23 (46%)     20 (40%)                               
      Follicle, Cyst                                   2 (4%)       6 (12%)      2 (4%)       7 (14%)                               
      Follicular Cell, Hyperplasia                     6 (12%)     11 (22%)      5 (10%)     11 (22%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (49)         (49)         (49)         (48)                                   
      Degeneration, Cystic                            35 (71%)     46 (94%)     33 (67%)     43 (90%)                               
      Inflammation, Chronic                                         1 (2%)       1 (2%)                                             
   Ovary                                              (50)         (50)         (47)         (48)                                   
      Angiectasis                                      1 (2%)                                                                       
      Cyst                                            10 (20%)     10 (20%)      5 (11%)     10 (21%)                               
      Hemorrhage                                       3 (6%)       1 (2%)                    1 (2%)                                
      Hyperplasia, Tubular                                                       1 (2%)                                             
      Thrombosis                                                                 1 (2%)       1 (2%)                                
      Bilateral, Cyst                                                                         1 (2%)                                
   Uterus                                             (50)         (50)         (49)         (50)                                   
      Cyst                                             3 (6%)                                                                       
      Hemorrhage                                       1 (2%)       2 (4%)       2 (4%)       1 (2%)                                
      Hydrometra                                      11 (22%)     20 (40%)     22 (45%)     13 (26%)                               
      Inflammation, Suppurative                        1 (2%)       1 (2%)       1 (2%)       1 (2%)                                
      Thrombosis                                                    1 (2%)       2 (4%)                                             
      Endometrium, Hyperplasia, Cystic                45 (90%)     45 (90%)     36 (73%)     42 (84%)                               
   Vagina                                             (50)         (49)         (45)         (49)                                   
      Cyst                                                                       1 (2%)                                             
      Fibrosis                                                                                1 (2%)                                
      Inflammation, Suppurative                                                               1 (2%)                                
      Epithelium, Hyperplasia                                       3 (6%)       2 (4%)       7 (14%)                               
      Epithelium, Hyperplasia, Atypical                                          2 (4%)       4 (8%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (49)         (50)         (50)                                   
      Angiectasis                                                                1 (2%)       1 (2%)                                
      Hyperplasia                                      1 (2%)       3 (6%)       3 (6%)       7 (14%)                               
      Necrosis                                         1 (2%)                                                                       
   Lymph Node                                         (7)          (5)          (7)          (10)                                   
      Bronchial, Hyperplasia                           1 (14%)                                                                      
      Iliac, Ectasia                                                                          1 (10%)                               
      Iliac, Hematopoietic Cell Proliferation                                    1 (14%)                                            
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    4                                                              
NTP Experiment-Test: 89006-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                                AZT                                            Date: 05/31/96  
Route: GAVAGE                                                                                                     Time: 12:30:48  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        VEHICLE      30 MG/KG     60 MG/KG     120                                       
                                                   CONTROL                                MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Iliac, Hemorrhage                                             1 (20%)                                                         
      Iliac, Hyperplasia, Histiocytic                  1 (14%)                                                                      
      Inguinal, Hyperplasia, Histiocytic                                                      1 (10%)                               
      Inguinal, Hyperplasia, Lymphoid                               1 (20%)      1 (14%)      2 (20%)                               
      Mediastinal, Hemorrhage                          1 (14%)      1 (20%)                                                         
      Mediastinal, Hyperplasia, Histiocytic                                                   1 (10%)                               
      Mediastinal, Hyperplasia, Lymphoid                                                      1 (10%)                               
      Renal, Hyperplasia, Lymphoid                                                            1 (10%)                               
   Lymph Node, Mandibular                             (50)         (46)         (48)         (48)                                   
      Hemorrhage                                                    1 (2%)       1 (2%)                                             
      Hyperplasia, Lymphoid                                         2 (4%)       3 (6%)       6 (13%)                               
      Infiltration Cellular, Mast Cell                 1 (2%)                    1 (2%)                                             
   Lymph Node, Mesenteric                             (50)         (47)         (48)         (47)                                   
      Ectasia                                                       1 (2%)       2 (4%)                                             
      Hematopoietic Cell Proliferation                                           1 (2%)                                             
      Hemorrhage                                       3 (6%)       5 (11%)      2 (4%)       5 (11%)                               
      Hyperplasia, Lymphoid                                         5 (11%)      3 (6%)       5 (11%)                               
   Spleen                                             (49)         (48)         (49)         (50)                                   
      Congestion                                       1 (2%)                    2 (4%)                                             
      Depletion Cellular                                            1 (2%)       3 (6%)       1 (2%)                                
      Hematopoietic Cell Proliferation                13 (27%)     12 (25%)     10 (20%)     14 (28%)                               
      Hyperplasia, Lymphoid                            8 (16%)      6 (13%)      2 (4%)       6 (12%)                               
   Thymus                                             (48)         (46)         (49)         (46)                                   
      Angiectasis                                                   1 (2%)                                                          
      Cyst                                                                       3 (6%)       1 (2%)                                
      Hyperplasia, Lymphoid                            4 (8%)       1 (2%)       1 (2%)       4 (9%)                                
      Necrosis                                                                   2 (4%)       2 (4%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (47)         (47)         (48)         (47)                                   
      Hyperplasia                                                   3 (6%)                    1 (2%)                                
   Skin                                               (50)         (49)         (50)         (50)                                   
      Inflammation, Chronic, Focal                     1 (2%)                    1 (2%)                                             
      Subcutaneous Tissue, Cyst Epithelial                                                                                          
          Inclusion                                                              1 (2%)                                             
      Subcutaneous Tissue, Edema                       1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (50)         (50)         (50)                                   
      Fibrous Osteodystrophy                                        4 (8%)                                                          
      Hyperostosis                                    37 (74%)     35 (70%)     33 (66%)     37 (74%)                               
      Cranium, Fibrous Osteodystrophy                                                         1 (2%)                                
   Skeletal Muscle                                    (50)         (50)         (50)         (50)                                   
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    5                                                              
NTP Experiment-Test: 89006-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                                AZT                                            Date: 05/31/96  
Route: GAVAGE                                                                                                     Time: 12:30:48  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        VEHICLE      30 MG/KG     60 MG/KG     120                                       
                                                   CONTROL                                MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
MUSCULOSKELETAL SYSTEM - CONT                                                                                                       
      Hyperplasia, Focal, Lymphoid                                               1 (2%)                                             
      Inflammation, Suppurative                        1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (50)         (50)                                   
      Atrophy, Focal                                   1 (2%)       3 (6%)                                                          
      Hemorrhage                                       1 (2%)                                                                       
      Vacuolization Cytoplasmic                        1 (2%)                    1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (49)         (50)         (50)         (50)                                   
      Congestion                                                    2 (4%)                    1 (2%)                                
      Foreign Body                                                               1 (2%)       1 (2%)                                
      Hemorrhage                                       3 (6%)                    3 (6%)       1 (2%)                                
      Hyperplasia, Histiocytic                                      2 (4%)       1 (2%)       2 (4%)                                
      Infiltration Cellular, Mixed Cell                1 (2%)                                                                       
      Pigmentation                                                               1 (2%)       1 (2%)                                
      Alveolar Epithelium, Hyperplasia                 2 (4%)                    4 (8%)       1 (2%)                                
      Mediastinum, Hemorrhage                                                    1 (2%)       1 (2%)                                
      Mediastinum, Inflammation, Chronic                                         2 (4%)       1 (2%)                                
      Mediastinum, Necrosis                                                      1 (2%)                                             
   Nose                                               (50)         (50)         (50)         (50)                                   
      Hemorrhage                                       1 (2%)                                                                       
      Mucosa, Glands, Dilatation, Focal                1 (2%)       2 (4%)                    2 (4%)                                
      Nasolacrimal Duct, Cyst                                       1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (3)                                    (1)                                    
      Cataract                                         1 (33%)                                                                      
      Fibrosis                                         2 (67%)                                                                      
      Cornea, Inflammation, Chronic                                                           1 (100%)                              
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)         (50)         (50)                                   
      Cyst                                                                                    1 (2%)                                
      Fibrosis, Focal                                                                         1 (2%)                                
      Infarct                                                       1 (2%)       2 (4%)                                             
      Metaplasia, Focal, Osseous                       1 (2%)                    2 (4%)                                             
      Nephropathy                                     29 (58%)     30 (60%)     31 (62%)     35 (70%)                               
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    6                                                              
NTP Experiment-Test: 89006-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                                AZT                                            Date: 05/31/96  
Route: GAVAGE                                                                                                     Time: 12:30:48  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        VEHICLE      30 MG/KG     60 MG/KG     120                                       
                                                   CONTROL                                MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
URINARY SYSTEM - CONT                                                                                                               
      Pelvis, Dilatation                                                         3 (6%)       3 (6%)                                
      Renal Tubule, Accumulation, Hyaline Droplet                   1 (2%)                    1 (2%)                                
      Renal Tubule, Dilatation                         1 (2%)       1 (2%)       3 (6%)                                             
      Renal Tubule, Necrosis                           1 (2%)                                                                       
      Renal Tubule, Pigmentation                       2 (4%)       1 (2%)                    2 (4%)                                
      Transitional Epithelium, Hyperplasia             1 (2%)                                                                       
   Urinary Bladder                                    (50)         (50)         (49)         (49)                                   
      Hyperplasia, Lymphoid                            1 (2%)       1 (2%)                                                          
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    7                                                              
NTP Experiment-Test: 89006-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                                AZT                                            Date: 05/31/96  
Route: GAVAGE                                                                                                     Time: 12:30:48  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          VEHICLE      30 MG/KG     60 MG/KG     120                                       
                                                   CONTROL                                MG/KG                                     
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Natural Death                                     12            6            9            4                                     
    Moribund Sacrifice                                 6            9            9            4                                     
    Accidently Killed                                                            2                                                  
    Dosing Accident                                                              1                                                  
  Survivors                                                                                                                         
    Terminal Sacrifice                                32           35           29           42                                     
  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (50)         (50)         (49)         (50)                                   
      Necrosis                                                                   1 (2%)                                             
      Muscularis, Inflammation, Chronic                                          1 (2%)                                             
   Gallbladder                                        (41)         (42)         (46)         (44)                                   
      Cyst                                                          1 (2%)                                                          
   Intestine Large, Cecum                             (47)         (48)         (45)         (49)                                   
      Hyperplasia, Lymphoid                                                      1 (2%)                                             
   Intestine Small, Duodenum                          (48)         (48)         (47)         (47)                                   
      Cyst                                                                       1 (2%)                                             
      Inflammation, Chronic, Focal                                                            1 (2%)                                
   Intestine Small, Jejunum                           (47)         (48)         (45)         (47)                                   
      Hyperplasia, Adenomatous                         1 (2%)                                                                       
   Intestine Small, Ileum                             (47)         (48)         (45)         (47)                                   
      Peyer's Patch, Hyperplasia, Lymphoid                          1 (2%)       1 (2%)                                             
   Liver                                              (50)         (50)         (50)         (50)                                   
      Angiectasis                                      3 (6%)       1 (2%)                                                          
      Basophilic Focus                                 5 (10%)      1 (2%)       3 (6%)       3 (6%)                                
      Clear Cell Focus                                 4 (8%)       3 (6%)                    4 (8%)                                
      Eosinophilic Focus                              12 (24%)     12 (24%)      7 (14%)     12 (24%)                               
      Inflammation, Chronic                           17 (34%)     24 (48%)     24 (48%)     16 (32%)                               
      Mixed Cell Focus                                 2 (4%)       4 (8%)       7 (14%)      4 (8%)                                
      Necrosis, Focal                                  8 (16%)      8 (16%)      9 (18%)      3 (6%)                                
      Vacuolization Cytoplasmic                        3 (6%)       1 (2%)       4 (8%)       3 (6%)                                
      Bile Duct, Cyst                                  1 (2%)                                 1 (2%)                                
      Bile Duct, Hyperplasia                           1 (2%)       9 (18%)      4 (8%)       3 (6%)                                
      Hepatocyte, Karyomegaly                          7 (14%)     10 (20%)     15 (30%)      5 (10%)                               
   Mesentery                                          (1)          (4)          (5)          (2)                                    
      Hemorrhage                                                                 1 (20%)                                            
      Inflammation, Chronic                                                      1 (20%)                                            
      Inflammation, Granulomatous                      1 (100%)                                                                     
      Thrombosis                                                    1 (25%)                                                         
      Artery, Inflammation, Chronic                                 1 (25%)                                                         
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    8                                                              
NTP Experiment-Test: 89006-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                                AZT                                            Date: 05/31/96  
Route: GAVAGE                                                                                                     Time: 12:30:48  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          VEHICLE      30 MG/KG     60 MG/KG     120                                       
                                                   CONTROL                                MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Fat, Necrosis                                                 2 (50%)      2 (40%)      2 (100%)                              
   Pancreas                                           (50)         (49)         (49)         (50)                                   
      Atrophy                                          1 (2%)       3 (6%)       3 (6%)                                             
      Inflammation, Granulomatous                      1 (2%)                                                                       
      Necrosis                                                      1 (2%)                                                          
      Thrombosis                                                                 1 (2%)                                             
      Artery, Inflammation, Chronic                                 1 (2%)                                                          
      Duct, Cyst                                                    1 (2%)       1 (2%)                                             
   Stomach, Forestomach                               (50)         (48)         (49)         (50)                                   
      Erosion                                          1 (2%)                    1 (2%)       1 (2%)                                
      Inflammation, Chronic                            2 (4%)       1 (2%)                                                          
      Ulcer                                            2 (4%)                                 1 (2%)                                
      Epithelium, Hyperplasia                          7 (14%)      4 (8%)       3 (6%)       1 (2%)                                
   Stomach, Glandular                                 (50)         (48)         (49)         (50)                                   
      Erosion                                                       1 (2%)       4 (8%)                                             
      Mineralization                                   1 (2%)       1 (2%)       2 (4%)       2 (4%)                                
      Pigmentation, Focal                                                        1 (2%)                                             
      Glands, Degeneration, Cystic, Focal                           2 (4%)       1 (2%)       2 (4%)                                
   Tooth                                              (2)          (2)          (7)          (1)                                    
      Developmental Malformation                       2 (100%)     2 (100%)     7 (100%)     1 (100%)                              
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (50)         (48)         (50)         (50)                                   
      Inflammation, Chronic                            1 (2%)                                 2 (4%)                                
   Heart                                              (50)         (50)         (50)         (50)                                   
      Fibrosis                                         1 (2%)                                                                       
      Inflammation, Chronic, Focal                     2 (4%)       4 (8%)                    1 (2%)                                
      Mineralization                                                             1 (2%)                                             
      Thrombosis                                                    1 (2%)       2 (4%)       1 (2%)                                
      Artery, Inflammation, Chronic                    1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (49)         (49)         (49)                                   
      Accessory Adrenal Cortical Nodule                1 (2%)       1 (2%)                                                          
      Cyst                                                                       1 (2%)       1 (2%)                                
      Cytoplasmic Alteration, Focal                    5 (10%)     11 (22%)      8 (16%)     18 (37%)                               
      Hyperplasia, Focal                               3 (6%)       1 (2%)       3 (6%)       5 (10%)                               
      Hypertrophy, Focal                              10 (20%)     17 (35%)      8 (16%)      7 (14%)                               
      Inflammation, Chronic, Focal                                               1 (2%)                                             
      Capsule, Hyperplasia, Focal                      3 (6%)                    2 (4%)       1 (2%)                                
   Adrenal Medulla                                    (50)         (49)         (48)         (49)                                   
      Hyperplasia                                                   1 (2%)       1 (2%)                                             
   Parathyroid Gland                                  (46)         (45)         (45)         (49)                                   
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    9                                                              
NTP Experiment-Test: 89006-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                                AZT                                            Date: 05/31/96  
Route: GAVAGE                                                                                                     Time: 12:30:48  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          VEHICLE      30 MG/KG     60 MG/KG     120                                       
                                                   CONTROL                                MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Cyst                                             1 (2%)                    1 (2%)       1 (2%)                                
   Pituitary Gland                                    (40)         (46)         (42)         (47)                                   
      Pars Distalis, Cyst                              1 (3%)       2 (4%)       1 (2%)       3 (6%)                                
      Pars Distalis, Cytoplasmic Alteration, Focal                                            1 (2%)                                
      Pars Distalis, Hyperplasia, Focal                                                       1 (2%)                                
   Thyroid Gland                                      (50)         (49)         (48)         (50)                                   
      Degeneration, Cystic, Focal                     15 (30%)     18 (37%)     11 (23%)     16 (32%)                               
      Follicle, Cyst                                   8 (16%)      4 (8%)       2 (4%)       5 (10%)                               
      Follicular Cell, Hyperplasia                     8 (16%)     10 (20%)     11 (23%)      9 (18%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (50)         (49)         (50)         (50)                                   
      Granuloma Sperm                                  1 (2%)                                                                       
      Spermatocele                                     1 (2%)       1 (2%)                                                          
   Preputial Gland                                    (48)         (50)         (50)         (49)                                   
      Degeneration, Cystic                            39 (81%)     46 (92%)     44 (88%)     45 (92%)                               
      Inflammation, Chronic                            4 (8%)       5 (10%)      2 (4%)                                             
   Prostate                                           (50)         (49)         (50)         (50)                                   
      Inflammation, Chronic                                         3 (6%)                                                          
      Inflammation, Chronic, Focal                     3 (6%)                                 2 (4%)                                
      Epithelium, Hyperplasia, Focal                   2 (4%)                                 1 (2%)                                
   Seminal Vesicle                                    (50)         (49)         (50)         (50)                                   
      Angiectasis                                      1 (2%)       1 (2%)                    4 (8%)                                
      Congestion                                       1 (2%)                                                                       
      Inflammation, Chronic                            1 (2%)                                 1 (2%)                                
   Testes                                             (50)         (49)         (50)         (50)                                   
      Germinal Epithelium, Degeneration                1 (2%)       1 (2%)                    1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (50)         (49)         (50)                                   
      Angiectasis                                                   1 (2%)       1 (2%)       1 (2%)                                
      Hyperplasia                                      2 (4%)       6 (12%)      6 (12%)      1 (2%)                                
   Lymph Node                                         (6)          (7)          (5)          (1)                                    
      Inguinal, Hyperplasia, Lymphoid                                            1 (20%)                                            
      Inguinal, Pigmentation                           1 (17%)      2 (29%)      1 (20%)                                            
      Mediastinal, Hyperplasia, Lymphoid               1 (17%)                   1 (20%)                                            
      Mediastinal, Inflammation, Granulomatous         1 (17%)                                                                      
      Pancreatic, Hyperplasia, Lymphoid                1 (17%)                                                                      
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   10                                                              
NTP Experiment-Test: 89006-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                                AZT                                            Date: 05/31/96  
Route: GAVAGE                                                                                                     Time: 12:30:48  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          VEHICLE      30 MG/KG     60 MG/KG     120                                       
                                                   CONTROL                                MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
   Lymph Node, Mandibular                             (49)         (48)         (49)         (50)                                   
      Hemorrhage                                                    1 (2%)                                                          
      Hyperplasia, Histiocytic                                                                1 (2%)                                
      Hyperplasia, Lymphoid                                         1 (2%)       1 (2%)       1 (2%)                                
      Infiltration Cellular, Mast Cell                                           1 (2%)                                             
   Lymph Node, Mesenteric                             (48)         (49)         (49)         (49)                                   
      Ectasia                                          5 (10%)      4 (8%)       1 (2%)       3 (6%)                                
      Fibrosis                                         1 (2%)                                                                       
      Hemorrhage                                      20 (42%)     31 (63%)     21 (43%)     25 (51%)                               
      Hyperplasia, Lymphoid                            3 (6%)       3 (6%)       3 (6%)       4 (8%)                                
      Inflammation, Granulomatous                      1 (2%)                                                                       
   Spleen                                             (50)         (49)         (48)         (50)                                   
      Angiectasis                                      1 (2%)                                                                       
      Depletion Cellular                               1 (2%)                    1 (2%)       6 (12%)                               
      Hematopoietic Cell Proliferation                18 (36%)     16 (33%)     14 (29%)     11 (22%)                               
      Hyperplasia, Lymphoid                            2 (4%)       1 (2%)       2 (4%)       2 (4%)                                
      Necrosis, Focal                                               1 (2%)                                                          
   Thymus                                             (41)         (44)         (41)         (35)                                   
      Cyst                                             6 (15%)     11 (25%)      5 (12%)      4 (11%)                               
      Mineralization                                                1 (2%)                                                          
      Necrosis                                                                   1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (15)         (10)         (15)         (5)                                    
      Inflammation, Chronic                                         1 (10%)                                                         
   Skin                                               (50)         (50)         (50)         (50)                                   
      Subcutaneous Tissue, Edema                                    1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (50)         (50)         (50)                                   
      Hyperostosis                                    30 (60%)     36 (72%)     28 (56%)     41 (82%)                               
   Skeletal Muscle                                    (50)         (50)         (50)         (50)                                   
      Necrosis                                                                   1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (49)         (50)                                   
      Hemorrhage                                                    1 (2%)                                                          
   Spinal Cord                                        (1)          (1)                                                              
      Degeneration                                     1 (100%)                                                                     
      Hemorrhage, Focal                                1 (100%)                                                                     
____________________________________________________________________________________________________________________________________
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   11                                                              
NTP Experiment-Test: 89006-06         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                                AZT                                            Date: 05/31/96  
Route: GAVAGE                                                                                                     Time: 12:30:48  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          VEHICLE      30 MG/KG     60 MG/KG     120                                       
                                                   CONTROL                                MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (50)         (50)         (50)                                   
      Hemorrhage                                       2 (4%)       1 (2%)       2 (4%)       3 (6%)                                
      Hyperplasia, Histiocytic                         2 (4%)       2 (4%)       1 (2%)                                             
      Hyperplasia, Lymphoid                                                      1 (2%)                                             
      Infiltration Cellular, Mixed Cell                             1 (2%)       1 (2%)       1 (2%)                                
      Inflammation, Chronic                                         1 (2%)       1 (2%)       1 (2%)                                
      Alveolar Epithelium, Hyperplasia                 6 (12%)      3 (6%)       1 (2%)       8 (16%)                               
   Nose                                               (50)         (50)         (49)         (50)                                   
      Nasolacrimal Duct, Inflammation, Suppurative                               1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                                                       (1)                                    
      Cornea, Inflammation, Chronic                                                           1 (100%)                              
   Harderian Gland                                    (3)          (7)          (2)          (10)                                   
      Hyperplasia, Focal                                            1 (14%)                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (48)         (49)         (50)                                   
      Cyst                                             2 (4%)                    1 (2%)                                             
      Infarct                                          1 (2%)       2 (4%)       1 (2%)       2 (4%)                                
      Metaplasia, Focal, Osseous                       1 (2%)       3 (6%)                    1 (2%)                                
      Nephropathy                                     45 (90%)     44 (92%)     44 (90%)     49 (98%)                               
      Thrombosis                                                                              1 (2%)                                
      Papilla, Necrosis                                                                       1 (2%)                                
      Pelvis, Dilatation                                            1 (2%)                                                          
      Renal Tubule, Accumulation, Hyaline Droplet                   1 (2%)                                                          
      Renal Tubule, Dilatation                                      1 (2%)                    1 (2%)                                
      Renal Tubule, Hyperplasia, Focal                              1 (2%)                                                          
      Renal Tubule, Pigmentation                       2 (4%)                    1 (2%)       1 (2%)                                
   Urethra                                            (1)          (1)                       (1)                                    
      Inflammation, Chronic                            1 (100%)     1 (100%)                  1 (100%)                              
   Urinary Bladder                                    (50)         (50)         (50)         (50)                                   
      Hemorrhage                                       1 (2%)                                                                       
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   12                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------